| Harmons's Pharmacy #73 | |
| 5454 S Redwood Rd, Taylorsville, Utah 84123 | |
| (801) 967-9185 |
| Name | Harmons's Pharmacy #73 |
|---|---|
| Organization Name | Harmon City Inc |
| Location | 5454 S Redwood Rd, Taylorsville, Utah 84123 |
| Type | Community/Retail Pharmacy |
| Phone | (801) 967-9185 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Elsevier announced today the winners of the Asian Young Women Researcher Awards, a joint development between its flagship product Scopus(R), the world's largest abstract and citation database of peer-reviewed literature and the Third World Organisation for Women in Science (TWOWS) and TWAS, the academy of sciences for the developing world.
A recent study from the University of Eastern Finland in collaboration with Deakin University, Australia, shows that recurrent major depressive disorder (MDD) in men is associated with lower bone density. The use of antidepressants was also associated with lower bone mineral density (BMD), but this association was dependent on the person's weight and site of bone measurement.
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, is pleased to announce preliminary results from Part 1 of the Phase 1/2 clinical trial of its DNA ImmunoBody vaccine in patients with Stage III/IV malignant melanoma.
› Verified 1 days ago
| NPI Number | 1275546111 |
| Organization Name | HARMON CITY INC |
| Doing Business As | HARMONS PHARMACY #73 |
| Type | Community/Retail Pharmacy |
| Address | 5454 S Redwood Rd, Taylorsville, UT 84123 |
| Phone Number | 801-967-9185 |
News Archive
Elsevier announced today the winners of the Asian Young Women Researcher Awards, a joint development between its flagship product Scopus(R), the world's largest abstract and citation database of peer-reviewed literature and the Third World Organisation for Women in Science (TWOWS) and TWAS, the academy of sciences for the developing world.
A recent study from the University of Eastern Finland in collaboration with Deakin University, Australia, shows that recurrent major depressive disorder (MDD) in men is associated with lower bone density. The use of antidepressants was also associated with lower bone mineral density (BMD), but this association was dependent on the person's weight and site of bone measurement.
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, is pleased to announce preliminary results from Part 1 of the Phase 1/2 clinical trial of its DNA ImmunoBody vaccine in patients with Stage III/IV malignant melanoma.
› Verified 1 days ago
News Archive
Elsevier announced today the winners of the Asian Young Women Researcher Awards, a joint development between its flagship product Scopus(R), the world's largest abstract and citation database of peer-reviewed literature and the Third World Organisation for Women in Science (TWOWS) and TWAS, the academy of sciences for the developing world.
A recent study from the University of Eastern Finland in collaboration with Deakin University, Australia, shows that recurrent major depressive disorder (MDD) in men is associated with lower bone density. The use of antidepressants was also associated with lower bone mineral density (BMD), but this association was dependent on the person's weight and site of bone measurement.
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, is pleased to announce preliminary results from Part 1 of the Phase 1/2 clinical trial of its DNA ImmunoBody vaccine in patients with Stage III/IV malignant melanoma.
› Verified 1 days ago
Cns Professional Services Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3685 W 6200 S, Taylorsville, Utah 84129 Phone: (801) 233-6120 | |
Cns Respiratory Services Type: Home Infusion Therapy Pharmacy Location: 3685 West 6200 South, Taylorsville, Utah 84129 Phone: (801) 973-0900 | |
Harmons's Pharmacy #73 Type: Community/Retail Pharmacy Location: 5454 S Redwood Rd, Taylorsville, Utah 84123 Phone: (801) 967-9185 | |
Standard Opticla Company Type: Medicare Supplier Location: 3754 W 5400 S, Taylorsville, Utah 84129 Phone: (801) 964-9911 | |
Walgreens #6961 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4668 S Redwood Rd, Taylorsville, Utah 84123 Phone: (801) 967-4972 |